Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ferrara

Showing results (231-240 of 286) with videos related to

Pageof 29
Sort By:
Nature Medicine|March 21, 1998
Vascular endothelial growth factor is essential for corpus luteum angiogenesisN Ferrara, H Chen, T Davis-Smyth, et al.
Journal of Medicinal Chemistry|January 5, 1996
Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portionK S Atwal, F N Ferrara, C Z Ding, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosisJ L Shifren, J F Tseng, C J Zaloudek, et al.
Journal of Medicinal Chemistry|February 20, 2004
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitorsKarnail S Atwal, Paulina Wang, W Lynn Rogers, et al.
Nature|April 4, 1996
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneN Ferrara, K Carver-Moore, H Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritisA E Koch, L A Harlow, G K Haines, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteinsL P Aiello, E A Pierce, E D Foley, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factorA Gossmann, T H Helbich, S Mesiano, et al.
Urologic Oncology|January 14, 2011
Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumorsA Kirschenbaum, J P Wang, M Ren, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1992
Early manifestations of dementing illness: treatment with glycosaminoglycan polysulfateT A Ban, L C Morey, O K Fjetland, et al.
Pageof 29

Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
Nature Medicine|March 21, 1998
Vascular endothelial growth factor is essential for corpus luteum angiogenesisN Ferrara, H Chen, T Davis-Smyth, et al.
Journal of Medicinal Chemistry|January 5, 1996
Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portionK S Atwal, F N Ferrara, C Z Ding, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosisJ L Shifren, J F Tseng, C J Zaloudek, et al.
Journal of Medicinal Chemistry|February 20, 2004
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitorsKarnail S Atwal, Paulina Wang, W Lynn Rogers, et al.
Nature|April 4, 1996
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneN Ferrara, K Carver-Moore, H Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritisA E Koch, L A Harlow, G K Haines, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteinsL P Aiello, E A Pierce, E D Foley, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factorA Gossmann, T H Helbich, S Mesiano, et al.
Urologic Oncology|January 14, 2011
Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumorsA Kirschenbaum, J P Wang, M Ren, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1992
Early manifestations of dementing illness: treatment with glycosaminoglycan polysulfateT A Ban, L C Morey, O K Fjetland, et al.
Pageof 29